In vitro evaluation of atone analogs as dermal penetration enhancers

International Journal of Pharmaceutics

Volumn 161, Issue 2, 1998, Pages 169-178

  Michniak, B B ^a   Player, M R ^b   Godwin, D A ^c   Lockhart, C C ^d   Sowell, J W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Human Motor Control Section   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Enhancers; Hairless mouse skin; Hydrocortisone; Percutaneous absorption; Steroids

Indexed keywords

1 DODECANOYL 2 PIPERIDINONE; 1 DODECANOYL 2 PYRROLIDINONE; 1 DODECANOYLPIPERIDINE; 1 DODECANOYLPYRROLIDINE; 1 DODECYL 2 PIPERIDONE; 1 DODECYL 2 PYRROLIDINONE; 2 DECYLCYCLOHEXANONE; 2 DECYLCYCLOPENTANONE; 4 ACETYLMORPHOLINE; 4 DODECANOYLTHIOMORPHOLINE; HYDROCORTISONE; LAUROCAPRAM; N (1 OXODODECYL)MORPHOLINE; N ACETYLCAPROLACTAM; N DODECYLTRICYCLO[3.3.1.1]DECANE 1 CARBOXAMIDE; N,N DIDODECYLACETAMIDE; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN; SKIN ABSORPTION; TECHNIQUE;

EID: 0032559533     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00349-9     Document Type: Article

References (30)

1. Allan G. Azone® Smith E.W., Maibach H.I. Percutaneous Penetration Enhancers. 1995;129-136 CRC Press, Boca Raton, FL.
2. Bolton, S., 1990. Pharmaceutical Statistics: Practical and Clinical Applications. Dekker, New York, pp. 117-181, 262-302.
3. Bouwstra J.A., Bodde H.E. Human SC barrier impairment by N-alkylazacycloheptanones: a mechanistic study of drug flux enhancement, Azone® mobility and protein and lipid perturbation. Smith E.W., Maibach H.I. Percutaneous Penetration Enhancers. 1995;137-164 CRC Press, Boca Raton, FL.
4. Brain K.R., Hadgraft J., Walters K.A. Significance of electrostatic interactions in the modification of the permeability of ceramide membranes. Brain K.R., James V.J., Walters K.A. Prediction of Percutaneous Penetration. 1993;166-173 STS, Cardiff.
5. Büyütktimkin S., Büyüktimkin N., Rytting J.H. Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino) propionate on the transepidermal delivery of indomethacin clonidine and hydrocortisone. Pharm. Res. 10:1993;1632-1637.
6. Chien Y.W. Novel Drug Delivery Systems: Fundamentals, Developmental Concepts, Biomedical Assessments. 1982;551-553 Dekker, New York.
7. Harris W.T., Tenjarla S.N., Holbrook J.M., Smith J., Mead C., Entrekin J. n-Pentyl N-acetylprolinate. A new skin penetration enhancer. J. Pharm. Sci. 84:1995;640-642.
8. Hori M., Satoh S., Maibach H.I. Classification of penetration enhancers: a conceptual diagram. J. Pharm. Pharmacol. 42:1990;71-72.
9. Lambert W.J., Kudlar R.J., Hollard J.M., Curry J.T. A biodegradable transdermal penetration enhancer based on N-(2-hydroxyethyl)-2-pyrrolidone. I. Synthesis and characterization. Int. J. Pharm. 45:1993;181-192.
10. Michniak B.B., Chapman J.M., Seyda K.L. Facilitated transport of two model steroids by esters and amides of clofibric acid. J. Pharm. Sci. 82:1993c;214-219.
11. Michniak B.B., Player M.R., Chapman J.M. Jr., Sowell J.W. Sr. Azone analogs as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention. J. Control. Release. 32:1994b;147-154.
12. Michniak B.B., Player M.R., Chapman J.M. Jr., Sowell J.W. Sr. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers: I. Int. J. Pharm. 91:1993a;85-93.
13. Michniak B.B., Player M.R., Fuhrman L.C., Christensen C.A., Chapman J.M. Jr., Sowell J.W. Sr. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers: II. (Thio)amides. Int. J. Pharm. 94:1993b;203-210.
14. Michniak B.B., Player M.R., Fuhrman L.C., Christensen C.A., Chapman J.M. Jr., Sowell J.W. Sr. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers: III. Acyclic amides. Int. J. Pharm. 110:1994a;231-239.
15. Michniak B.B., Player M.R., Godwin D.A., Phillips C.A., Sowell J.W. Sr. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers: IV. Amines. Int. J. Pharm. 116:1995;201-209.
16. Miniskanian, G., Peck, J.V., 1990. US Patent Application, 199 801; Chem. Abstr., 113, 158682k.
17. Moghimi H.R., Williams A.C., Barry B.W. A lamellar matrix model for SC intercellular lipids IV. Effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int. J. Pharm. 145:1996;49-59.
18. Nikishin, G.I., Somov, G.V., Petrov, A.D., 1961. Free radical addition of cyclopentanone and cyclohexanone to α-olefins and allyl ethers. Izvest. Akad. Nauk S.S.S.R., Otdel. Khim. Nauk., pp. 2065-2071; through Chem. Abstr., 56 (1962) 7155.
19. Nikishin, G.I., Somov, G.V., Petrov, A.D., 1961. Free radical addition of cyclopentanone and cyclohexanone to α-olefins and allyl ethers. Izvest. Akad. Nauk S.S.S.R., Otdel. Khim. Nauk., pp. 2065-2071; through Chem. Abstr., 56 (1962) 7155.
20. Parks T.M., Cleek R.L., Bunge A.L. Chemical release from topical formulations across synthetic membranes: infinite dose. J. Pharm. Sci. 86:1997;187-192.
21. Pellet M.A., Castellano S., Hadgraft J., Davis A.F. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Release. 46:1997;205-214.
22. Pfister W.R., Dean S., Hsieh S.T. Permeation enhancers compatible with transdermal drug delivery systems. I. Selection and formulation considerations. Pharm. Tech. 8:1990;132-140.
23. Phillips C.A., Michniak B.B. Topical application of Azone analogs to hairless mouse skin: a histopathological study. Int. J. Pharm. 125:1995;63-71.
24. Rajadhaksha, V.J., Pfister, W.R., 1996. Oxazolidinones: optimizing delivery of active ingredients in skin care products. Drug Cosmet. Ind., March, 36-107.
25. Sasaki H., Kojima M., Mori Y., Nakamura J., Shibasaki J. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin and flurbiprofen. J. Pharm. Sci. 80:1991;533-538.
26. Sloan K.B., Beall H.D., Weimar W.R., Villanueva R. The effect of receptor phase composition on the permeability of hairless mouse skin in diffusion cell experiments. Int. J. Pharm. 73:1991;97-104.
27. Tanchuk, A., Yu, V., Kotenko, S.I., Voloshchuk, T.P., 1980. Synthesis of 6-hydroxy acids and 4-alkylbutyrolactones. Ukr. Khim. Zh., 46 (7), 763-767; through Chem. Abstr., 93, 238795h.
28. Tanchuk, A., Yu, V., Kotenko, S.I., Voloshchuk, T.P., 1980. Synthesis of 6-hydroxy acids and 4-alkylbutyrolactones. Ukr. Khim. Zh., 46 (7), 763-767; through Chem. Abstr., 93, 238795h.
29. Yano T., Shimozono Y., Manako T., Fukuda K., Yahiro S., Kanji N. Profile of pirotiodecane (HPE-101): a new potential penetration enhancer. Smith E.W., Maibach H.I. Percutaneous Penetration Enhancers. 1995;233-244 CRC Press, Boca Raton, FL.
30. Yokomizo Y. Effects of phospholipids on the percutaneous penetration of drugs through the dorsal skin of the guinea pig, in vitro. 3. The effects of phospholipids on several drugs having different polarities. J. Control. Release. 42:1996;217-228.